RBPWorld - a comprehensive database of RNA Binding Proteins

Drugs target to TUBA1A

Drug name	Drug type	Disease/phenotype	Mechanism of action(MoA)	Phase	Status	Source
PACLITAXEL POLIGLUMEX	Small molecule	non-small cell lung carcinoma	Tubulin stabiliser	2.0	Completed	ClinicalTrials
T-900607	Small molecule	ovarian neoplasm	Tubulin disrupting agent	2.0	Unknown status	ClinicalTrials
DAVUNETIDE	Protein	Cognitive impairment	Tubulin stabiliser	2.0	Completed	ClinicalTrials
FOSBRETABULIN	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
DOLASTATIN-10	Small molecule	kidney cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOLASTATIN-10	Small molecule	sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	urogenital neoplasm	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	squamous cell carcinoma	Tubulin stabiliser	1.0	Completed	ClinicalTrials
SOBLIDOTIN	Small molecule	sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	head and neck carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
SAGOPILONE	Small molecule	neoplasm	Tubulin stabiliser	1.0	Completed	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	Primary Peritoneal Serous Adenocarcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	ovarian cancer	Tubulin stabiliser	1.0	Completed	ClinicalTrials
TUSAMITAMAB RAVTANSINE	Antibody	neoplasm	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
SOBLIDOTIN	Small molecule	lung cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ANG1005	Protein	glioblastoma multiforme	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOLASTATIN-10	Small molecule	malignant tumor of extrahepatic bile duct	Tubulin inhibitor	2.0	Completed	ClinicalTrials
TUSAMITAMAB RAVTANSINE	Antibody	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
DAVUNETIDE	Protein	progressive supranuclear palsy	Tubulin stabiliser	2.0	Completed	ClinicalTrials
T-900607	Small molecule	hepatocellular carcinoma	Tubulin disrupting agent	2.0	Unknown status	ClinicalTrials
T-900607	Small molecule	non-Hodgkins lymphoma	Tubulin disrupting agent	2.0	Terminated	ClinicalTrials
FOSBRETABULIN	Small molecule	wet macular degeneration	Tubulin inhibitor	1.0	Completed	ClinicalTrials
FOSBRETABULIN DISODIUM	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
FOSBRETABULIN	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	Endometrial Clear Cell Adenocarcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
VINFLUNINE	Small molecule	small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	urogenital neoplasm	Tubulin inhibitor	3.0	Recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	non-small cell lung carcinoma	Tubulin stabiliser	3.0	Terminated	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	primary peritoneal carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
MILATAXEL	Small molecule	colonic neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ARX-788	Unknown	breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
ARX-788	Unknown	triple-negative breast cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
VINFLUNINE	Small molecule	urinary bladder cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	ovarian cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	multiple myeloma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
FOSBRETABULIN	Small molecule	cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	lung cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VINFLUNINE	Small molecule	urothelial carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
FOSBRETABULIN DISODIUM	Small molecule	cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
DOLASTATIN-10	Small molecule	leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PLINABULIN	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Active, not recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	prostate adenocarcinoma	Tubulin stabiliser	2.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	Malignant Ovarian Brenner Tumor	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
TUSAMITAMAB RAVTANSINE	Antibody	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
FOSBRETABULIN	Small molecule	neuroendocrine neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	ovarian clear cell adenocarcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	breast cancer	Tubulin stabiliser	2.0	Withdrawn	ClinicalTrials
SAGOPILONE	Small molecule	glioblastoma multiforme	Tubulin stabiliser	2.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	ovarian serous adenocarcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	peritoneum cancer	Tubulin stabiliser	1.0	Completed	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	small cell lung carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
SAGOPILONE	Small molecule	non-small cell lung carcinoma	Tubulin stabiliser	2.0	Completed	ClinicalTrials
SAGOPILONE	Small molecule	prostate cancer	Tubulin stabiliser	2.0	Completed	ClinicalTrials
TUSAMITAMAB RAVTANSINE	Antibody	neoplasm	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	non-small cell lung carcinoma	Tubulin stabiliser	2.0	Terminated	ClinicalTrials
FOSBRETABULIN DISODIUM	Small molecule	wet macular degeneration	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PLINABULIN	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	Endometrial Serous Adenocarcinoma	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	neuroblastoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PLOCABULIN	Small molecule	colorectal cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PLOCABULIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
FOSBRETABULIN	Small molecule	thyroid cancer	Tubulin inhibitor	3.0	Withdrawn	ClinicalTrials
VINFLUNINE	Small molecule	penile neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
SAGOPILONE	Small molecule	breast neoplasm	Tubulin stabiliser	2.0	Completed	ClinicalTrials
ARX-788	Unknown	breast neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PLINABULIN	Small molecule	multiple myeloma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	Fallopian Tube Serous Adenocarcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
FOSBRETABULIN	Small molecule	neuroendocrine neoplasm	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	breast cancer	Tubulin stabiliser	2.0	Completed	ClinicalTrials
CROLIBULIN	Small molecule	thyroid cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
INDIBULIN	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
DOLASTATIN-10	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
OMBRABULIN	Small molecule	ovarian cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	fallopian tube cancer	Tubulin stabiliser	1.0	Completed	ClinicalTrials
SAGOPILONE	Small molecule	small cell lung carcinoma	Tubulin stabiliser	2.0	Terminated	ClinicalTrials
DAVUNETIDE	Protein	schizophrenia	Tubulin stabiliser	2.0	Completed	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	Pleuropulmonary blastoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	neoplasm	Tubulin inhibitor	4.0	-	ATC
FOSBRETABULIN DISODIUM	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
T-900607	Small molecule	gastric cancer	Tubulin disrupting agent	2.0	Completed	ClinicalTrials
FOSBRETABULIN	Small molecule	ovarian cancer	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	leukemia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	undifferentiated carcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
VINFLUNINE	Small molecule	breast cancer	Tubulin inhibitor	3.0	Completed	ClinicalTrials
PRALUZATAMAB RAVTANSINE	Antibody	breast cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	fallopian tube cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VERUBULIN	Small molecule	neoplasm	Tubulin disrupting agent	1.0	Completed	ClinicalTrials
MILATAXEL	Small molecule	rectum cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	rhabdomyosarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
ANG1005	Protein	malignant glioma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VERUBULIN	Small molecule	glioblastoma multiforme	Tubulin disrupting agent	2.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	lung cancer	Tubulin stabiliser	3.0	Terminated	ClinicalTrials
ANG1005	Protein	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	ovarian mucinous adenocarcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
DOLASTATIN-10	Small molecule	lymphoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	colorectal cancer	Tubulin stabiliser	1.0	Completed	ClinicalTrials
PLINABULIN	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Not yet recruiting	ClinicalTrials
MILATAXEL	Small molecule	mesothelioma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
SOBLIDOTIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PLINABULIN	Small molecule	neutropenia	Tubulin inhibitor	3.0	Active, not recruiting	ClinicalTrials
VINFLUNINE	Small molecule	urinary bladder carcinoma	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	breast cancer	Tubulin stabiliser	1.0	Completed	ClinicalTrials
FOSBRETABULIN TROMETHAMINE	Small molecule	ovarian cancer	Tubulin disrupting agent	2.0	Terminated	ClinicalTrials
ARX-788	Unknown	cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
FOSBRETABULIN	Small molecule	neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PLINABULIN	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	neoplasm	Tubulin stabiliser	3.0	-	ATC
OMBRABULIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
ARX-788	Unknown	breast neoplasm	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	malignant peripheral nerve sheath tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Withdrawn	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	prostate cancer	Tubulin stabiliser	2.0	Terminated	ClinicalTrials
DOLASTATIN-10	Small molecule	myelodysplastic syndrome	Tubulin inhibitor	1.0	Completed	ClinicalTrials
OMBRABULIN	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	bladder transitional cell carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	brain neoplasm	Tubulin stabiliser	2.0	Completed	ClinicalTrials
SAGOPILONE	Small molecule	melanoma	Tubulin stabiliser	2.0	Completed	ClinicalTrials
FOSBRETABULIN TROMETHAMINE	Small molecule	neuroendocrine neoplasm	Tubulin disrupting agent	2.0	Completed	ClinicalTrials
DOLASTATIN-10	Small molecule	gallbladder cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
SAGOPILONE	Small molecule	small cell lung carcinoma	Tubulin stabiliser	1.0	Completed	ClinicalTrials
DOLASTATIN-10	Small molecule	pancreatic carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
MILATAXEL	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
LEXIBULIN	Small molecule	multiple myeloma	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
VERUBULIN	Small molecule	brain neoplasm	Tubulin disrupting agent	1.0	Completed	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	synovial sarcoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
T-900607	Small molecule	liver cancer	Tubulin disrupting agent	2.0	Completed	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	endometrial cancer	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
FOSBRETABULIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
ARX-788	Unknown	angiosarcoma	Tubulin inhibitor	2.0	Recruiting	ClinicalTrials
CROLIBULIN	Small molecule	cancer	Tubulin inhibitor	1.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	Transitional Cell Carcinoma	Tubulin inhibitor	2.0	Unknown status	ClinicalTrials
ANG1005	Protein	brain neoplasm	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	Ovarian Transitional Cell Carcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
VINFLUNINE	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
PLINABULIN	Small molecule	small cell lung carcinoma	Tubulin inhibitor	1.0	Recruiting	ClinicalTrials
SAGOPILONE	Small molecule	Central Nervous System Neoplasm	Tubulin stabiliser	2.0	Completed	ClinicalTrials
DOLASTATIN-10	Small molecule	leukemia	Tubulin inhibitor	1.0	Completed	ClinicalTrials
SAGOPILONE	Small molecule	breast cancer	Tubulin stabiliser	2.0	Completed	ClinicalTrials
ARX-788	Unknown	breast cancer	Tubulin inhibitor	2.0	Active, not recruiting	ClinicalTrials
FOSBRETABULIN DISODIUM	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
OMBRABULIN	Small molecule	sarcoma	Tubulin inhibitor	3.0	Completed	ClinicalTrials
FOSBRETABULIN	Small molecule	head and neck malignant neoplasia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	breast cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
INDIBULIN	Small molecule	breast cancer	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
DOLASTATIN-10	Small molecule	prostate cancer	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PLINABULIN	Small molecule	neutropenia	Tubulin inhibitor	2.0	Completed	ClinicalTrials
LEXIBULIN	Small molecule	glioblastoma multiforme	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
VINFLUNINE	Small molecule	gastric cancer	Tubulin inhibitor	2.0	Terminated	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	breast cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
PACLITAXEL POLIGLUMEX	Small molecule	endometrioid carcinoma	Tubulin stabiliser	3.0	Active, not recruiting	ClinicalTrials
INDIBULIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Unknown status	ClinicalTrials
INDIBULIN	Small molecule	neoplasm	Tubulin inhibitor	1.0	Completed	ClinicalTrials
SAGOPILONE	Small molecule	ovarian neoplasm	Tubulin stabiliser	2.0	Completed	ClinicalTrials
PLINABULIN	Small molecule	neutropenia	Tubulin inhibitor	3.0	Completed	ClinicalTrials
VINFLUNINE	Small molecule	urinary bladder cancer	Tubulin inhibitor	1.0	Withdrawn	ClinicalTrials
MIRVETUXIMAB SORAVTANSINE	Antibody	breast carcinoma	Tubulin inhibitor	2.0	Completed	ClinicalTrials
PLINABULIN	Small molecule	non-small cell lung carcinoma	Tubulin inhibitor	1.0	Terminated	ClinicalTrials
LORVOTUZUMAB MERTANSINE	Antibody	Wilms tumor	Tubulin inhibitor	2.0	Completed	ClinicalTrials

Welcome to

RBP World!

Drugs target to TUBA1A

Targets details